We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Barr Challenges Janssen's Patents on Risperdal Tablets
Barr Challenges Janssen's Patents on Risperdal Tablets
November 1, 2005
Barr Laboratories is challenging the patents protecting Janssen Pharmaceutica's antipsychotic Risperdal M-Tab (risperidone orally disintegrating tablets) in 0.5-, 1- and 2-mg dosage strengths.
